Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-Risk Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01995344
What this trial is testing

TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment

Who this might be right for
Metastatic Melanoma
The Christie NHS Foundation Trust 2
Testing effectiveness (Phase 2)Study completedNCT00616564
What this trial is testing

Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Mt. Sinai Medical Center, Miami 36
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Large-scale testing (Phase 3)Active Not RecruitingNCT05608291
What this trial is testing

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 1,564
Early research (Phase 1)Ended earlyNCT04234113
What this trial is testing

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Thyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more
SOTIO Biotech AG 115
Not applicableStudy completedNCT02206360
What this trial is testing

Pancreatic Cancer Early Detection Program

Who this might be right for
Pancreatic CancerPancreas CancerPancreatic Adenocarcinoma+8 more
White Plains Hospital 181
Not applicableStudy completedNCT02074605
What this trial is testing

Cognitive Effects of Interferon in Patients With Melanoma

Who this might be right for
Melanoma
University of Arizona 36
Testing effectiveness (Phase 2)Looking for participantsNCT07448831
What this trial is testing

A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.

Who this might be right for
Melanoma (Skin Cancer)
Universitair Ziekenhuis Brussel 49
Testing effectiveness (Phase 2)Ended earlyNCT03991130
What this trial is testing

High Dose IL-2 in Combination With Anti-PD-1

Who this might be right for
MelanomaRenal Cell Carcinoma, Metastatic
Gregory Daniels 6
Testing effectiveness (Phase 2)Study completedNCT00610857
What this trial is testing

Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Ahmad Tarhini 37
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Testing effectiveness (Phase 2)Looking for participantsNCT06319196
What this trial is testing

Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma

Who this might be right for
Cutaneous MelanomaMelanoma Stage IVMucosal Melanoma
University Health Network, Toronto 54
Testing effectiveness (Phase 2)Ended earlyNCT01925118
What this trial is testing

Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2

Who this might be right for
Metastatic Malignant Melanoma and Renal Cell Carcinoma
Seoul National University Hospital 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT03767348
What this trial is testing

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Microsatellite Instability-High (MSI-H)Non-melanoma Skin Cancer (NMSC)+1 more
Replimune, Inc. 340
Large-scale testing (Phase 3)Looking for participantsNCT06246149
What this trial is testing

Adjuvant Tebentafusp in High Risk Ocular Melanoma

Who this might be right for
Uveal Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 290
Testing effectiveness (Phase 2)Study completedNCT01189383
What this trial is testing

IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Baylor Research Institute 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05270044
What this trial is testing

Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

Who this might be right for
Melanoma
Pierre Fabre Medicament 815
Large-scale testing (Phase 3)Study completedNCT02388906
What this trial is testing

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 906
Early research (Phase 1)Looking for participantsNCT06942143
What this trial is testing

An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors

Who this might be right for
SarcomaLung CancersMelanoma
Guangzhou FineImmune Biotechnology Co., LTD. 15
Large-scale testing (Phase 3)UnknownNCT00226408
What this trial is testing

Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

Who this might be right for
AdjuvantStage III Malignant MelanomaInterferon Alpha+1 more
Dermatologic Cooperative Oncology Group 600
Next Page